The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose oral cyclophosphamide-methotrexate maintenance (CMM) for receptor-negative early breast cancer (BC).
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Pierre Fabre; Taiho Pharmaceutical
 
Kathryn P. Gray
Stock and Other Ownership Interests - DYAX
 
Shari I. Gelber
No Relationships to Disclose
 
Istvan Lang
No Relationships to Disclose
 
Beat J. K. Thurlimann
Stock and Other Ownership Interests - Roche and Novartis; Roche and Novartis (I)
Honoraria - Roche
Travel, Accommodations, Expenses - Pierre Fabre
 
Lorenzo Gianni
No Relationships to Disclose
 
Ehtesham A. Abdi
No Relationships to Disclose
 
Karen N. Price
No Relationships to Disclose
 
Richard D. Gelber
Research Funding - AstraZeneca (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Giuseppe Viale
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Dako; Roche/Genentech
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Roche
 
Alan S. Coates
No Relationships to Disclose
 
Aron Goldhirsch
No Relationships to Disclose